Funded Biotech startups in New Jersey
Every company below filed a Form D with the SEC from a New Jersey address. Amounts are as reported on the filing, not estimates.
Updated Jul 31, 2026
- Companies
- 9
- Total raised
- $39.3M
- Filings
- 15
- Median round
- $1.0M
- Cities
- 8
CompanyCityLast filingLatest round
Hepion PharmaceuticalsNew Jersey diagnostics company developing non-invasive liquid…
Red Bank
Jul 31, 2026
$3.1M
TETmedical(Tethered Enzyme Technologies) is a clinical-stage…
Fair Haven
Jun 12, 2026
$3.5M
Optimeos Life SciencesPrinceton University spinout developing non-viral nanoparticle…
Princeton
May 22, 2026
$1.0M
SentrimedClinical-stage biopharmaceutical company in Mullica Hill, New…
Mullica Hill
May 8, 2026
$250K
Outlook TherapeuticsPioneering biopharmaceutical company specializing in the…
Iselin
Apr 23, 2026
N/A
Claris BiotherapeuticsPioneering biotechnology company dedicated to the development…
Jersey City
Sep 12, 2025
$2.3M
Cyclacel PharmaceuticalsClinical-stage biopharmaceutical company dedicated to…
Berkeley Heights
Mar 21, 2025
$1.0M
Grace TherapeuticsLate-stage biopharmaceutical company dedicated to the…
Princeton
Feb 10, 2025
$15.0M
IVIEW TherapeuticsClinical-stage biotechnology company dedicated to developing…
Cranbury
May 14, 2024
$9.2M
All 9 companies · most recent filing first
Most recent filings
9All 9 companies · most recent filing first